The influence of ribonucleic acid (RNA) and protein synthesis on the replication of the cloacinogenic factor Clo DF13 was studied in Escherichia coli cells and minicells. In chromosomeless minicells harboring the Clo DF13 factor, Clo DF13 deoxyribonucleic acid (DNA) synthesis is slightly stimulated after inhibition of protein synthesis by chloramphenicol or puromycin and continues for more than 8 h. When minicells were treated with rifampin, a specific inhibitor of DNA-dependent RNA polymerase, Clo DF13 RNA and DNA synthesis appeared to stop abruptly. In cells, the Clo DF13 factor continues to replicate during treatment with chloramphenicol long after chromosomal DNA synthesis ceases. When rifampin was included during chloramphenicol treatment of cells, synthesis of Clo DF13 plasmid DNA was blocked completely. Isolated, supercoiled Clo DF13 DNA, synthesized in cells or minicells in the presence of chloramphenicol, appeared to be sensitive to ribonuclease and alkali treatment.
These treatments convert a relatively large portion of the covalently closed Clo DF13 DNA to the open circular form, whereas supercoiled Clo DF13 DNA, isolated from non-chloramphenicol-treated cells or minicells, is not significantly affected by these treatments. These results indicate that RNA synthesis and specifically Clo DF13 RNA synthesis are involved in Clo DF13 DNA replication and that the covalently closed Clo DF13 DNA, synthesized in the presence of chloramphenicol, contains one or more RNA sequences. De novo synthesis of chromosomal and Clo DF13-specific proteins is not required for the replication of the Clo DF13 factor. Supercoiled Clo DF13 DNA, isolated from a polA107 (Clo DF13) strain which lacks the 5'-3' exonucleolytic activity of DNA polymerase I, is insensitive to ribonuclease or alkali treatment, indicating that in this mutant the RNA sequences are still removed from the RNA-DNA hybrid.
The cloacinogenic factor DF13 (Clo DF13) is a bacterial plasmid determining the production of the extracellular antibiotic protein cloacin DF13. The Clo DF13 factor originates from Enterobacter cloacae (34) ; however, Escherichia coli can serve as the host as well. The non-transmissible Clo DF13 factor, a relatively small circular deoxyribonucleic acid (DNA) molecule (molecular weight 6 x 106) with a contour length of 3.0 um (36) , is present in E. coli cells to the extent of 15 copies per cell (25a) . The Clo DF13 DNA directs the synthesis of at least four messenger ribonucleic acid (mRNA) species and eight proteins (25, 25a) . The function of only one protein, cloacin DF13, is known. Cloacin DF13 inhibits protein synthesis of sensitive cells by a specific cleavage of 16S ribosomal RNA (rRNA) near its 3' terminus (17, 18) . This 16 action of cloacin DF13 resembles closely that of colicin E3; in some other aspects its action corresponds to that of Col El (4, 17, 18, 32) .
With respect to the replication, there is a remarkable difference between transmissible and non-transmissible plasmids. Whereas transmissible plasmids seem to require DNA polymerase III for their replication (15) , Clo DF13 shows, like other non-transmissible plasmids such as Col El and minicircular DNA of E. coli 15, a unique dependence on DNA polymerase I (13, 16, 22, 23, 36a) . DNA polymerase II (36a) and DNA polymerase III (15, 16, 36a) seem not to be required for the replication of these latter plasmids. Whereas (27) , or Clo DF13 (this report). RNA synthesis is a prerequisite for the replication of chromosomal DNA and for DNA of transmissible as well as non-transmissible plasmids (3, 5, 7, 8, 12, 20, 24, 26, 27, 33, 35) . It has been shown that rifampinsensitive RNA synthesis is required for the initiation of chromosomal DNA replication at the fixed origin (26) . The synthesis of "Okazakipieces" seems to require rifampin-insensitive RNA primers (35) . It has been shown that Col El DNA, synthesized in the presence of CAP, contains one or more ribonucleotides (3) . RNA primer sequences must be rapidly removed from the DNA-RNA hybrid. It has been suggested that the 5' -3' exonucleolytic activity of DNA polymerase I is involved in the degradation of RNA primers (31, 38) . The 5' -3' exonucleolytic activity, however, seems not to be essential for the maintenance of the DNA polymerase I-dependent Clo DF13 factor in E. coli (36a) . Isolation of Clo DF13 DNA. Covalently closed Clo DF13 DNA was purified from labeled cells before and after incubation with CAP (150 Mg/ml) for 18 h. Cells were lysed by the method of Clewell and Helinski (9), with Brij-58 (final concentration, 1%, wt/vol) as detergent. The crude lysate was centrifuged at 48,000 x g for 30 min in an MSE 75 ultracentrifuge. This centrifugation step pellets the bulk of the chromosomal DNA, leaving plasmid DNA in the supernatant. DNA in the supernatant fraction (cleared lysate) was fractionated by the dye-buoyant density centrifugation procedure of Radloff et al. (29) as described previously (36a). Fractions containing supercoiled Clo DF13 DNA were pooled from the dye-buoyant density gradient. The ethidium bromide was removed from the pooled fractions by a single passage through a column (0.5 by 3.5 cm) of analytical-grade Dowex-50 resin. CsCl was then removed by dialysis at 4 C for 12 Determination of radioactivity. All radioactive samples except those from the sucrose gradients were collected onto Whatman 3 MM filter discs and precipitated with cold 10% trichloroacetic acid. After being washed successively with 5% trichloroacetic acid, ethanol-ether and ether, the filters were dried and placed in scintillation vials containing 10 Fig. 1 ) is separated from the chromosomal DNA and from the open circular Clo DF13 DNA (peak I in Fig. 1 ). In contrast to chromosomal DNA, the Clo DF13 plasmid continues to replicate in the presence of CAP (Fig. 1) .
To investigate the possibility that during CAP treatment Clo DF13 DNA with aberrant S values is synthesized, fractions of peak II (Fig.  1A and 1B) were pooled and analyzed by sucrose gradient centrifugation as described before (36a) . No differences in S values between non-CAP-treated Clo DF13 DNA and CAPtreated Clo DF13 DNA were observed (gradients not shown). When rifampin was included during CAP treatment, no incorporation of label into Clo DF13 DNA was observed (Fig. 1C) . Because the synthesis of Clo DF13 DNA does not depend on de novo protein synthesis, as demonstrated by its insensitivity towards CAP (Fig. 1B) (Fig. 2) . The presence of rifampin in the incubation medium inhibits the synthesis of DNA drastically. Chromosomal DNA synthesis due to contaminating cells present in the minicell preparation is unlikely (less than 100 cells per 108 minicells). To exclude this possibility, however, identical experiments were performed with plasmidless minicells, isolated from strain P678-54, with a similar grade of purity. Only a low background level of incorporation is observed in noncloacinogenic minicells (Fig. 2B) (Fig. 3) show that the presence of CAP or puromycin in the incubation media reduced the incorporation to its initial background level. From these results we conclude that Clo DF13 DNA synthesis does not depend on de novo synthesis of Clo DF13-specific proteins. Similar experiments were conducted to assess the effects of rifampin, puromycin, and CAP treatment on RNA synthesis in minicell preparations. Treatment of Clo DF13-containing minicells with rifampin caused an almost complete reduction in the incorporation of [3H ]uridine into Clo DF13 RNA. The rate of incorporation was not reduced, but slightly stimulated, by treatment of minicells with CAP or puromycin (Fig. 4) (Fig. 5A and Table 1 ).
The sensitivity of supercoiled Clo DF13 DNA to alkali treatment was examined by incubating CAP-treated Clo DF13 DNA and non-CAPtreated Clo DF13 DNA at pH 13.0. After 90 min of incubation at 37 C, the pH was reduced to 8.0 and the reaction mixtures were analyzed by sucrose gradient centrifugation. After centrifugation, the percent supercoiled Clo DF13 DNA of total Clo DF13 DNA recovered from the gradients was determined ( Table 1) . Incubation of CAP-treated Clo DF13 DNA at pH 13 induces a loss of the covalently closed form, whereas non-CAP-treated Clo DF13 DNA is scarcely (1.9% conversion) affected by the high pH conditions. 7A ). This result indicates that in a polA107 strain RNA sequences are still removed from the Clo DF13 DNA molecule. Clo DF13 DNA molecules, synthesized in the presence of CAP in polA107 (Clo DF13) bacteria, are sensitive to RNase treatment (Fig. 7B) .
Identical experiments were performed with purified Clo DF13 DNA synthesized in the presence and absence of CAP in minicells. Minicells contain little if any chromosomal DNA; therefore, isolated DNA from minicells was hot purified by CsCl-EB gradients after the clearing centrifugation step, but directly used for incubation experiments with RNases and alkali treatment. Treatment of Clo DF13 DNA, isolated from CAP-treated minicells, with ribonuclease A and T, induces a conversion of the plasmid DNA from the covalently closed form to an open circular form of about 20% (Fig. 6B and Table 1 ). The covalently closed form of non-CAP-treated Clo DF13 DNA is not significantly affected by this treatment (Fig. 6A and Table 1 ). The different response of non-CAPand CAP-treated Clo DF13 DNA, synthesized in minicells, on alkaline treatment is shown in Table 1B . About 50% of the CAP-treated Clo DF13 DNA is nicked during incubation at high pH, in contrast to non-CAP-treated Clo DF13 DNA which is only affected slightly by this treatment. These results suggest that, in the presence of CAP, supercoiled RNA containing Clo DF13 DNA is synthesized in cells and minicells.
Role of the 5' -3' exonucleolytic activity of DNA polymerase I in the removal of RNA primer sequences. It has been shown that the Clo DF13 plasmid could be maintained in an E. coli polA107 strain (36a). The polA107 strain (KMBL1789), isolated by Glickman et al. (14) Wovcha and Warner (38) , since this enzyme exhibits a 5' 3' exonucleolytic activity which selectively attacks a DNA strand containing uracil instead of thymine. In addition, DNA polymerase I has been shown to be a prerequisite for the replication of Clo DF13 factor (36a). We therefore investigated a possible role of the 5' -3' exonucleolytic activity of DNA polymerase I in the removal of RNA primer sequences. The sensitivity of supercoiled Clo DF13 DNA, isolated from a polA107 (Clo DF13) strain, to ribonuclease and to alkali treatment was determined. Covalently closed Clo DF13 DNA, synthesized in this polA107 strain which lacks the 5' -3' exonucleolytic activity of DNA polymerase I, appeared to be insensitive to these treatments. Apparently no RNA sequences are present in supercoiled Clo DF13 DNA isolated from the polA107 (Clo DF13) strain. This observation indicates that either the 5' -3' exonucleolytic activity of DNA polymerase I is not involved in degradation of primer RNA or, besides this nuclease, another enzyme(s) exists which is responsible for the removal of RNA primer sequences. It seems most likely that the RNA is on the 5' end of the chain, and therefore the 3' 5' exonucleolytic activity of DNA polymerase I is probably not relevant. We cannot exclude, however, altemative explanations, e.g., that the remaining activity of the mutant enzyme present in the polA107 strain (19) could account for degradation of ribonucleotides, or that the mutant retains in vivo its 5' 3' exonucleolytic activity.
